Chi‐Cheng Lu
- Molecular Medicine top 1%
- Curcumin's Biomedical Applications 12
- Toxicology top 0.5%
- Biochemistry top 1%
- Pharmacology top 0.5%
-
- Cell death mechanisms and regulation 21
- Natural product bioactivities and synthesis 13
- RNA Interference and Gene Delivery 12
- Retinoids in leukemia and cellular processes 12
- Genomics, phytochemicals, and oxidative stress 10
-
- Autophagy in Disease and Therapy 13
-
- Quinazolinone synthesis and applications 9
Chi‐Cheng Lu
135 papers receiving 5.0k citations
Peers
Comparison fields: 5 of 142
- Molecular Medicine 418
- Applied Microbiology and Biotechnology 163
- Toxicology 260
- Biochemistry 328
- Pharmacology 420
Countries citing papers authored by Chi‐Cheng Lu
This map shows the geographic impact of Chi‐Cheng Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chi‐Cheng Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chi‐Cheng Lu more than expected).
Fields of papers citing papers by Chi‐Cheng Lu
This network shows the impact of papers produced by Chi‐Cheng Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chi‐Cheng Lu. The network helps show where Chi‐Cheng Lu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Chi‐Cheng Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 4 | |
| 2 | 2023 | 0 | |
| 3 | 2023 | 4 | |
| 4 | 2022 | 9 | |
| 5 | 2022 | 13 | |
| 6 | 2021 | 10 | |
| 7 | 2018 | 20 | |
| 8 | 2018 | 29 | |
| 9 | 2015 | 24 | |
| 10 | 2014 | 35 | |
| 11 | 2014 | 36 | |
| 12 | 2013 | 44 | |
| 13 | 2012 | 112 | |
| 14 | 2012 | 7 | |
| 15 | 2011 | 20 | |
| 16 | 2010 | 188 | |
| 17 | 2009 | 75 | |
| 18 | 2009 | 19 | |
| 19 | 2009 | 54 | |
| 20 | 2009 | 37 |
About Chi‐Cheng Lu
Chi‐Cheng Lu is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine, Toxicology, Pharmacology and Cancer Research, having authored 140 papers that have together received 5.0k indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (21 papers), Natural product bioactivities and synthesis (13 papers), Autophagy in Disease and Therapy (13 papers), RNA Interference and Gene Delivery (12 papers), Retinoids in leukemia and cellular processes (12 papers), Curcumin's Biomedical Applications (12 papers), Genomics, phytochemicals, and oxidative stress (10 papers) and Quinazolinone synthesis and applications (9 papers). The work is most often cited by research in Molecular Medicine (418 citations), Applied Microbiology and Biotechnology (163 citations), Toxicology (260 citations), Biochemistry (328 citations) and Pharmacology (420 citations). Chi‐Cheng Lu has collaborated with scholars based in Taiwan, China and Japan. Frequent co-authors include Jai‐Sing Yang, Jing‐Gung Chung, Gow‐Chin Yen, Jo‐Hua Chiang, Yuan‐Man Hsu, Fuu‐Jen Tsai, Yu‐Ting Cheng, Chih‐Hsiung Wu, Fu‐An Chen and Tsung‐Han Lee. Their work appears in journals such as Oncology Reports, International Journal of Oncology, Environmental Toxicology, Biomedicine and Journal of Agricultural and Food Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.